Radcliffe Capital Management’s Forbion European Acquisition Corp. Warrants FRBNW Stock Holding History

Radcliffe Capital Management’s Portfolio FRBNW Stock Details FRBNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43,190	Closed	-$21.6K	–	451
2023 Q3	$21.6K	Sell	43,190 -34,043	-44%	-$19.7K	﹤0.01%	258
2023 Q2	$30.2K	Sell	77,233 -6,100	-7%	-$2.19K	﹤0.01%	285
2023 Q1	$12.3K	Hold	83,333	–	–	﹤0.01%	505
2022 Q4	$861K	Hold	83,333	–	–	0.03%	714
2022 Q3	$842K	Hold	83,333	–	–	0.02%	975
2022 Q2	$835K	Hold	83,333	–	–	0.02%	1031
2022 Q1	$831K	Buy	+83,333	New	+$34.3K	0.02%	1029

Radcliffe Capital Management's FRBNW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of Forbion European Acquisition Corp. Warrants (FRBNW) in Q4 2023, closing a stake of 43,190 shares — an estimated $21.6K sold.

Radcliffe Capital Management first reported a position in FRBNW in Q1 2022 and held it in 7 quarters. The position peaked at $861K in Q4 2022. 0 funds tracked by Wall St. Rank hold FRBNW as of Q4 2023.

Radcliffe Capital Management reported no remaining Forbion European Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Radcliffe Capital Management sold 43,190 Forbion European Acquisition Corp. Warrants shares in Q4 2023, an estimated $21.6K.
Radcliffe Capital Management first reported a position in Forbion European Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Radcliffe Capital Management's Forbion European Acquisition Corp. Warrants position peaked at $861K in Q4 2022.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Warrants as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.